BeOne Medicines
ONC
#717
Rank
ยฃ24.51 B
Marketcap
ยฃ213.43
Share price
2.20%
Change (1 day)
5.27%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Earnings for BeOne Medicines (ONC)

Earnings in 2025 (TTM): ยฃ0.35 Billion

According to BeOne Medicines's latest financial reports the company's current earnings are ยฃ5.34 Billion. , an increase over its 2024 earnings that were of -ยฃ0.43 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BeOne Medicines from 2015 to 2025

Annual earnings

Year Earnings Change
2025 ยฃ0.35 B-183.61%
2024 -ยฃ0.43 Billion-52.95%
2023 -ยฃ0.92 Billion-32.52%
2022 -ยฃ1.35 Billion24.39%
2021 -ยฃ1.09 Billion-13.21%
2020 -ยฃ1.26 Billion72.69%
2019 -ยฃ0.73 Billion36.01%
2018 -ยฃ0.54 Billion616.83%
2017 -ยฃ74.25 Million-15.24%
2016 -ยฃ87.6 Million107.91%
2015 -ยฃ42.14 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-ยฃ0.13 Billion-133.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-ยฃ13.7 Million-103.82%๐Ÿ‡บ๐Ÿ‡ธ USA